ExCellThera

About:

ExCellThera is an advanced clinical stage biotechnology company.

Description:

ExCellThera is an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand blood stem and immune cells for therapeutic use. ExCellThera’s lead technology, ECT-001, combines a proprietary small molecule, UM171, and an optimized culture system. In pursuit of better treatments for patients, the company is building out its portfolio of products, as well as supporting best-in-class clinical trials.

Total Funding Amount:

$6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2015-01-01

Founders:

Anne Marinier, Guy Sauvageau

Number of Employees:

11-50

Last Funding Date:

2020-02-11

IPO Status:

Private

Industries: